https://www.avient.com/sites/default/files/2025-02/ColorMatrix Amosorb 4020L Product Bulletin.pdf
Part of the ColorMatrix™ Amosorb™ range,
ColorMatrix Amosorb 4020L is a shelf life extender
oxygen scavenging additive designed for medium to
long-term shelf life applications and is ideally suited
for demanding juices, condiments, sauces, and beer
products without stingent CO2 egress protection.
The additive is designed for use with recycled
PET (rPET) and delivers full oxygen scavenging
performance with up to 100% rPET content.
https://www.avient.com/investor-center/news/polyone-signs-definitive-agreement-acquire-clariant-color-and-additive-masterbatch-business
Together, we will benefit from the combined ingenuity, passion and expertise of two global leaders in color design, additive technologies and sustainable solutions," said
https://www.avient.com/resource-center?document_type=62&all=1
Avient is an intermediate supplier of specialty polymers and related raw materials designed to meet the specifications of its manufacturing customers.
https://www.avient.com/sites/default/files/2021-01/artisan-abs-fingerprint-detector-housing.pdf
FINGERPRINT
DETECTOR
H O U S I N G
• Metallic effect
• In-mold labeling replacement
• Overmold on PC
• Chemical resistance
• Achieved metallic effects without secondary
step of painting
• Customized colors to achieve desired
aesthetics of the design
• Improved cost-effectiveness
• Provided live technical support from concept
to production
Artisan™ AR7300-8001 M Silver Formulation
KEY REQUIRMENTS
WHY AVIENT ?
https://www.avient.com/sites/default/files/2024-07/TPE Whitepaper_0.pdf
TPEs also allow for greater
design freedom, an extended product portfolio
and lower extractables.
Finetool designed its cap to meet the stringent performance, compliance
and cost requirements of its OEM, a leading producer of sterile IV
solutions.
If you’re considering a
switch to TPEs, our expert team
can consult on:
• Part design
• Application environment
• Tooling and machine
selection
For additional information on the
opportunities associated with
TPEs, call us at +1.844.4AVIENT
(1.844.428.4368) or visit
avient.com.
https://www.avient.com/sites/default/files/2020-08/2020-composite-springs-product-selection-install-guide.pdf
PRODUCT SELECTION & INSTALLATION GUIDE
COMPOSITE
SPRINGS
VIBRATORY CONVEYORS
AND SEATING
FEATURE BENEFIT
• Exceptional fatigue resistance
• Corrosion resistance
• Creep resistance
Fewer failures for longer spring life, less frequent
replacement, and a more reliable end product
• High strength-to-weight ratio—less than half
the weight of steel
• High spring rate and deep deflection
• Custom designs to support off-axis loads
Stronger springs can mean fewer are needed
in an application for overall cost savings
• Common sizes in inventory
• Custom design and finishing capabilities
Fast, dependable service, ready-to-install product
and customization options to boost your
manufacturing efficiency
PRODUCT
DESCRIPTION
Thermoset composite springs from Avient are
engineered with proprietary vinyl ester or epoxy
resins and unidirectional fiber reinforcement
technologies.
Mechanical stop required: In chair installation and
applications, a mechanical stop must be added to the chair
design to prevent over-stressing of the spring.
https://www.avient.com/sites/default/files/resources/POL%2520Gabelli%2520IR%2520Presentation%2520w%2520Non-GAAP%252003%252020%25202014.pdf
Use of Non-GAAP Measures
Page 3
PolyOne Commodity to Specialty Transformation
Page 4
• Continue specialty
transformation
• Targeting $2.50
Adjusted EPS by
2015, nearly
double 2013 EPS
• Drive double digit
operating income
and adjusted EPS
growth
• 17 consecutive
quarters of double-
digit adjusted EPS
growth
• Shift to faster
growing, high
margin, less cyclical
end markets
• Key acquisitions
propel current and
future growth, as
well as margin
expansion
• Established
aggressive 2015
targets
• Steve Newlin
Appointed,
Chairman, President
and CEO
• New leadership
team appointed
• Implementation of
four pillar strategy
• Focus on value
based selling,
investment in
commercial
resources and
innovation to drive
transformation
• Volume driven,
commodity
producer
• Heavily tied to
cyclical end markets
• Performance largely
dependent on non-
controlling joint
ventures
2000-2005 2006 - 2009 2010 – 2013 2014 and beyond
-150.00%
-50.00%
50.00%
150.00%
250.00%
350.00%
PolyOne S&P 500 Russell 2000 Dow Jones Chemical
All time high of
$38.38
March 7th, 2014
• 17 consecutive quarters of
double digit EPS growth
• 49% CAGR adjusted EPS
expansion 2006-2013
• 2013 stock price increased
73% versus 30% growth in the
S&P
• More than seven fold increase in
market cap: $0.5b $3.6b
Strategy and Execution Drive Results
Page 5
Appliance
4%
Building &
Construction
13%
Wire & Cable
9%
Electrical &
Electronics
5%
Consumer
10%Packaging
16%
Industrial
12%
HealthCare
11%
Transportation
18%
Misc.
2%
United
States
66%
Europe
14%
Canada
7%
Asia
6%
Latin
America
7%
PP&S
20%
Specialty
53%
Distribution
27%
0.12
0.27 0.21
0.13
0.68
0.82
1.00
1.31
2.50
$0.00
$0.25
$0.50
$0.75
$1.00
$1.25
$1.50
$1.75
$2.00
$2.25
$2.50
2006 2007 2008 2009 2010 2011 2012 2013 2015
Target
A
dj
us
te
d
Ea
rn
in
gs
P
er
S
ha
re
2013 Revenues: $3.8 Billion
End Markets
2013 Revenues: $3.8 Billion
EPS
Page 6
PolyOne
At A Glance
Old
PolyOne Transformation
*Operating Income excludes corporate charges and special items
2%
34%
43%
62%
65-
75%
0%
20%
40%
60%
80%
100%
2005 2008 2010 2013 2015
%
o
f O
pe
ra
ti
ng
In
co
m
e*
JV's Performance Products & Solutions Distribution Specialty
Specialty OI $5M $46M $87M $195M Target
Mix Shift Highlights Specialty Transformation
2015
Target
Page 7
2006 2013 2015
“Where we were” “Where we are” Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 12.2% 12 – 16%
Global Specialty Engineered
Materials 1.1% 9.3% 12 – 16%
Designed Structures & Solutions -- 5.6% 8 – 10%
Performance Products &
Solutions 5.4% 7.2% 9 – 12%
Distribution 2.6% 5.9% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 62% 65 – 75%
3) ROIC* (after-tax) 5.0% 9.1% 15%
4) Adjusted EPS Growth N/A 31%
Double Digit
Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Page 8
Bridge To $2.50 Adjusted EPS By 2015
2015 EPS: $2.50
2013 EPS: $1.31
Mid single digit
revenue CAGR
Page 9
Mergers & Acquisitions
Spartech accretion
Incremental share buybacks
Ongoing LSS Programs
(50-100 bps/yr)
Accelerated Innovation &
Mix Improvement
Innovation Drives Earnings Growth
$20.3
$52.3
2006 2013
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
*Percentage of Specialty Platform revenue from products introduced in last five years
Page 10
14.3%
30.7%
2006 2013
Specialty Platform
Gross Margin %
19.5%
43.0%
2006 2013
Healthcare
Consumer
Packaging and Additive Technology
Transportation
Page 11
Unique and Innovative Solutions that Help
Customers Win
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG
Net Debt / EBITDA* = 1.8x
$48
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Significant Debt Maturities
As of December 31, 2013
($ millions)
Page 12
Coupon Rates: 7.500% 7.375% 5.250%
Debt Maturities & Pension Funding – 12/31/13
*TTM 12/31/2013 ** includes US-qualified plans only
60%
100%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 2013
Pension Funding**
As of December 31, 2013
Free Cash Flow and Strong Balance Sheet Fund Investment
• Targets that expand our:
• Specialty offerings
• End market presence
• Geographic footprint
• Operating Margin
• Synergy opportunities
• Adjacent material solutions
• Expanding our sales,
marketing, and technical
capabilities
• Investing in operational and
LSS initiatives (including
synergy capture)
• Manufacturing alignment Organic
Growth
Share
Repurchases
Dividends
Acquisitions
Page 13
$0.16
$0.20
$0.24
$0.32
$0.00
$0.10
$0.20
$0.30
$0.40
2011 2012 2013 2014
Annual Dividend
• Repurchased ~5 million
shares in 2013
• 15 million shares
are available for
repurchase under
the current
authorization
The New PolyOne: A Specialty Growth Company
2015 Target: $2.50 Adjusted EPS
Why Invest In PolyOne?
Platform operating income mix percentage 2005Y* 2006* 2008Y* 2010Y* 2013Y
Global Specialty Engineered Materials $ 0.4 $ 3.9 $ 17.6 $ 49.7 $ 57.2
Global Color, Additives and Inks 4.3 8.9 28.1 37.7 104.0
Designed Structures and Solutions - - - - 33.4
Specialty Platform $ 4.7 $ 12.8 $ 45.7 $ 87.4 $ 194.6
Performance Products and Solutions 75.7 64.2 31.3 54.0 56.0
Distribution 19.5 19.2 28.1 42.0 63.3
SunBelt Joint venture 91.9 102.9 28.6 18.9 -
Corporate (51.5) 34.5 (425.1) (27.7) (82.4)
Operating income (loss) GAAP $ 140.3 $ 233.6 $ (291.4) $ 174.6 $ 231.5
Less: Corporate operating expense 51.5 (34.5) 425.1 27.7 82.4
Operating income excluding Corporate $ 191.8 $ 199.1 $ 133.7 $ 202.3 $ 313.9
Specialty platform operating mix percentage 2% 6% 34% 43% 62%
* Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.
Reconciliation to Condensed Consolidated Balance Sheets 2013
Short-term debt and current portion of long-term debt $ 12.7
Long-term debt 976.2
Less cash and cash equivalents (365.2)
Net debt $ 623.7
Adjusted EBITDA 2013
Income before income taxes $ 151.0
Interest expense, net 63.5
Depreciation and amortization 108.8
Special items in EBITDA 31.7
Adjusted EBITDA $ 355.0
2
Platform sales and operating income (OI) 2006Y* 2013Y
Global Specialty Engineered Materials sales $ 345.3 $ 615.5
Global Color, Additives and Inks sales 531.8 852.3
Designed Structures and Solutions sales - 597.4
Specialty Platform sales 877.1 2,065.2
Performance Products and Solutions sales 1,166.2 773.2
PolyOne Distribution sales 732.8 1,075.2
Corporate and eliminations (153.7) (142.4)
Total sales $ 2,622.4 $ 3,771.2
Global Specialty Engineered Materials OI $ 3.9 $ 57.2
Global Color, Additives and Inks OI 8.9 104.0
Designed Structures & Solutions OI - 33.4
Specialty Platform OI 12.8 194.6
Performance Products and Solutions OI 64.2 56.0
PolyOne Distribution OI 19.2 63.3
Sunbelt Joint Venture OI 102.9 -
Corporate and eliminations (4.6) (52.4)
Special items in OI 39.1 (30.0)
Operating income GAAP 233.6 231.5
Sunbelt equity income (107.0) -
Special items in OI (39.1) 30.0
Adjusted operating income $ 87.5 $ 261.5
Global Specialty Engineered Materials - OI % of sales 1.1% 9.3%
Global Color, Additives and Inks - OI % of sales 1.7% 12.2%
Designed Structures & Solutions - OI % of sales - 5.6%
Specialty platform OI - % of sales 1.5% 9.4%
PP&S operating OI - % of sales 5.5% 7.2%
Distribution OI - % of sales 2.6% 5.9%
PolyOne OI adjusted - % of sales 3.3% 6.9%
* Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.
https://www.avient.com/sites/default/files/resources/PolyOne%25202017%2520Annual%2520Report.pdf
Nevertheless, we have management processes designed to rigorously protect our inventions and
trademarks.
We
also offer a wide range of services including materials testing, component analysis, custom formulation
development, colorant and additive services, part design assistance, structural analysis, process simulations, mold
design and flow analysis and extruder screw design.
These products are sold to over 6,500 custom injection molders and extruders who, in turn, convert them into
plastic parts that are sold to end-users in a wide range of industries.
https://www.avient.com/sites/default/files/resources/PolyOne%25202011%2520Annual%2520Report.pdf
These products are sold to
over 5,700 custom injection molders and extruders who, in turn, convert them
into plastic parts that are sold to end-users in a wide range of industries.
3) Facility is not included in manufacturing plants total as it is a design center/lab
These products are sold
to over 5,700 custom injection molders and extruders who, in turn, convert
them into plastic parts that are sold to end-users in a wide range of industries.
https://www.avient.com/sites/default/files/2024-03/Global Supplier Quality Manual_2024.pdf
The supplier shall ensure the products are
designed, produced, and tested in conformity with the requirements prescribed by industry
standards or within the supplier’s own QMS.
FDA-designed raw materials shall be produced
according to the requirements specified by the Food, Drug, and Cosmetic Act.
If a supplier is designated as medium or high risk,
improvement actions may involve – but will not be limited to – QF-05 completion, an on-site
audit request, and/or QMS development.
3.3 Supplier On-Site Audit
When deemed necessary, Avient will perform on-site supplier audits to verify suppliers’
compliance with this SQM.